The loss of the sense of smell, or anosmia, has long been documented as one of the most frequent and…
Read More
Scientists Solve Decades-Old Mystery of Plasma Asymmetry in Fusion Reactors by Identifying Toroidal Rotation as Key Factor
The pursuit of clean, virtually limitless energy through nuclear fusion has long been hampered by the volatile nature of plasma,…
Read More
Gan & Lee Pharmaceuticals Secures Key South Korean Partnership for Bofanglutide Development and Commercialization
Gan & Lee Pharmaceuticals has announced a significant licensing agreement with JW Pharmaceutical, granting the South Korean biopharmaceutical company exclusive…
Read More
Unraveling the Molecular Choreography of Bacterial Cell Division: UAB Scientists Reveal MraZ’s Dynamic Role in Orchestrating Growth
A groundbreaking study led by scientists at the Universitat Autònoma de Barcelona (UAB) has elucidated the intricate molecular mechanism governing…
Read More
Ludwig Cancer Research Unveils Synergistic Combination Therapy Targeting Differentiation Blockade in Acute Myelogenous Leukemia
The landscape of hematological oncology is facing a potential paradigm shift following a landmark study by Ludwig Cancer Research, which…
Read More
AI-Powered "GPS" Model Marks Paradigm Shift in Drug Discovery, Identifies Candidates for Liver Cancer and Pulmonary Fibrosis
A groundbreaking machine-learning model, dubbed "GPS" (Gene Expression Profile Predictor on Chemical Structures), has been unveiled by a multi-institute collaboration…
Read More
MEDVi’s Meteoric AI-Fueled Ascent Faces Scrutiny Amidst FDA Warnings, Allegations of Deceptive Marketing, and Multiple Lawsuits
A telehealth startup, MEDVi, recently lauded by The New York Times as a prime example of an AI-driven billion-dollar enterprise,…
Read More
Clinical Labs May Gain New Edge in Early Cancer Detection with Epigenetic Instability Liquid Biopsy
This groundbreaking research from the Johns Hopkins Kimmel Cancer Center marks a significant stride in the quest for more effective…
Read More
Bristol Myers Squibb and Oxford BioTherapeutics Forge Alliance to Pioneer Novel T-Cell Engager Therapies for Solid Tumors
Bristol Myers Squibb (BMS) and Oxford BioTherapeutics (OBT) have announced a significant strategic alliance aimed at discovering and developing a…
Read More
Oxford-Led Research Unveils Revolutionary Food Supplement to Combat Honeybee Decline
A groundbreaking food supplement, engineered to precisely mimic the essential nutrients bees derive from natural pollen, has been developed by…
Read MoreYOU MAY HAVE MISSED
